Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

February 28, 2011

Conditions
Type 2 Diabetes
Interventions
OTHER

ITCA 650

ITCA 650 (continuous delivery of exenatide in DUROS)

DRUG

Exenatide Injection

twice daily (BID) injections of exenatide commercially available Byetta: 5 mcg/dose first 12 weeks then 10 mcg/dose for 8 weeks

OTHER

Ex Inj/ITCA 650

twice-daily (BID) exenatide injection: 5 mcg/dose for 4 weeks then 10 mcg/dose for 8 weeks, followed by ITCA 650

Trial Locations (50)

11042

Study Site, New Hyde Park

23502

Study Site, Norfolk

28209

Study Site, Charlotte

28601

Study Site, Hickory

30328

Study Site, Sandy Springs

30342

Study Site, Atlanta

33025

Study Site, Miramar

33026

Study Site, Pembroke Pines

33143

Study Site, Miami

33169

Study Site, Miami

33183

Study Site, Miami

33709

Study Site, St. Petersburg

34203

Study Site, Bradenton

40503

Study Site, Lexington

45005

Study Site, Franklin

45212

Study Site, Cincinnati

45219

Study Site, Cincinnati

45429

Study Site, Kettering

46123

Study Site, Avon

48098

Study Site, Troy

48197

Study Site, Ypsilanti

49007

Study Site, Kalamazoo

49684

Study Site, Traverse City

55416

Study Site, Minneapolis

57702

Study Site, Rapid City

60607

Study Site, Chicago

67205

Study Site, Wichita

70112

Study Site, New Orleans

73069

Study Site, Norman

75039

Study Site, Irving

75230

Study Site, Dallas

75251

Study Site, Dallas

78205

Study Site, San Antonio

78229

Study Site, San Antonio

78749

Study Site, Austin

78752

Study Site, Austin

80501

Study Site, Longmont

81001

Study Site, Pueblo

83642

Study Site, Meridian

84088

Study Site, West Jordan

89119

Study Site, Las Vegas

91607

Study Site, Valley Village

91710

Study Site, Chino

91950

Study Site, National City

92037

Study Site, La Jolla

92161

Study Site, San Diego

95821

Study Site, Sacramento

97404

Study Site, Eugene

98502

Study Site, Olympia

99202

Study Site, Spokane

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY